SC1-PHE-CORONAVIRUS-2020
SC1-PHE-CORONAVIRUS-2020
18 projects · €67,755,562 total EU contribution (project-level) · 146 participating organizations · 23 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€67,755,562
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (19)
- Germany (17)
- France (17)
- Netherlands (15)
- Spain (12)
- UK (11)
- SE (9)
- BE (8)
- CH (7)
- DK (6)
- CN (5)
- PL (4)
- AT (3)
- FI (2)
- IE (2)
- PT (2)
- AL (1)
- CI (1)
- LT (1)
- NO (1)
- NP (1)
- RO (1)
- US (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- INSERM3 projects · FR
- KI3 projects · SE
- RIVM3 projects · NL
- Leiden University Medical Center2 projects · NL
- ADLEGO BIOMEDICAL AB2 projects · SE
- CSIC2 projects · ES
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2 projects · FR
- ERASMUS MC2 projects · NL
- FOHM2 projects · SE
- HZI2 projects · DE
- IP2 projects · FR
- INMI2 projects · IT
Projects
Page 1 of 2
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Rapid therapy development through Open nCoronavirus Vaccine Platform OPENCORONA · 101003666 | H2020 | €3,000,000 | €391,072 | Details |
Health Emergency Response in Interconnected Systems HERoS · 101003606 | H2020 | €2,855,410 | €353,373 | Details |
Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus Solnatide · 101003595 | H2020 | €1,626,025 | €310,938 | Details |
FIGHTING-OFF CORONAVIRUS (SARS-CoV-2) WITH BROAD-SPECTRUM ANTIVIRALS: ESTABLISHING ANIMAL VIRAL CHALLENGE MODEL Fight-nCoV · 101003555 | H2020 | €2,807,026 | €604,690 | Details |
Epidemic intelligence to minimize 2019-nCoV’s public health, economic and social impact in Europe EpiPose · 101003688 | H2020 | €4,548,391 | €284,000 | Details |
Combating 2019-nCoV: Advanced Nanobiosensing platforms for POC global diagnostics and surveillance CoNVat · 101003544 | H2020 | €2,547,152 | €692,406 | Details |
Rapid interaction profiling of 2019-nCoV for network-based deep drug-repurpose learning (DDRL) RiPCoN · 101003633 | H2020 | €1,230,635 | €197,500 | Details |
Development and validation of rapid molecular diagnostic test for nCoV19 HG nCoV19 test · 101003713 | H2020 | €931,605 | €61,875 | Details |
Rapid European SARS-CoV-2 Emergency research Response RECoVER · 101003589 | H2020 | €19,995,195 | €495,441 | Details |
Swift COronavirus therapeutics REsponse SCORE · 101003627 | H2020 | €2,576,063 | €51,489 | Details |